| dc.contributor.author |
Kehongo M. Nyanguru, Caroline Maina, Mutiat Ibrahim, James Kuria, Ephantus Ndirangu, Sospeter Ngoci Njeru, Abdullahi Abdulraheem, Edwin Murungi, Moses Obimbo, Adeyemi O. Aremu, Aloys Mosima Osano, Samwel Cheruiyot, Margaret O. Ilomuanya, Peter Waweru Mwangi, Elizabeth Kigondu |
|
| dc.description.abstract |
Introduction: While Flueggea virosa (Roxb. Ex Willd.) Royle root bark is
traditionally used in several parts of East Africa for fertility regulation, its
contraceptive potential has not been systematically investigated. Given the
paucity of safe, reversible, non-hormonal contraceptives for women, this study
evaluated a root bark fraction for sperm-disrupting, intravaginal contraceptive
activity using functional assays and a rabbit proof-of-concept model.
Methods: Following extraction and fractionation of authenticated root bark, the
resulting extracts were evaluated for cytotoxicity in Vero cells and for disruption of
human sperm functions by ascertaining immobilization, revival, viability, cervical
mucus penetration and acrosin-related activity. Thereafter, chemical profiling of
the most active fraction was performed using liquid chromatography-tandem
mass spectrometry (LC-MS/MS) for descriptive annotation. Moreover, in vivo
contraceptive efficacy and short-term local safety (10 days) were determined
after intravaginal administration of the fraction in rabbits by histological
examination of cervicovaginal tissues.
Results: The methanolic fraction (KBLM) demonstrated the strongest activity,
completely immobilizing sperm, abolishing sperm revival after washing, markedly
reducing sperm viability, strongly inhibiting cervical mucus penetration and
suppressing acrosin-related activity at 1.62 mg/mL. In a rabbit proof-ofconcept experiment, a single intravaginal dose prevented pregnancy at all
tested concentrations (3.9, 7.8, and 15.6 mg/mL). Besides, repeated
OPEN ACCESS
EDITED BY
Maša Knez Marevci,
University of Maribor, Slovenia
REVIEWED BY
Tushar Dhanani,
Florida Agricultural and Mechanical
University, United States
Parasuraman S,
AIMST University, Malaysia
*CORRESPONDENCE
Kehongo M. Nyanguru,
kehongo@mmarau.ac.ke,
kehongomoses1995@gmail.com
Elizabeth Kigondu,
m_kigondu@yahoo.com,
ekigondu@kemri.go.ke
RECEIVED 20 March 2026
REVISED 11 June 2026
ACCEPTED 15 June 2026
PUBLISHED 01 July 2026
CITATION
Nyanguru KM, Maina C, Ibrahim M, Kuria J,
Ndirangu E, Njeru SN, Abdulraheem A,
Murungi E, Obimbo M, Aremu AO,
Osano AM, Cheruiyot S, Ilomuanya MO,
Mwangi PW and Kigondu E (2026) Spermdisrupting activity of a root bark fraction of
Flueggea virosa (Roxb. ex willd.) royle
uncovered using LC-MS/MS profiling and
functional evaluation.
Front. Pharmacol. 17:1835308.
doi: 10.3389/fphar.2026.1835308
COPYRIGHT
© 2026 Nyanguru, Maina, Ibrahim, Kuria,
Ndirangu, Njeru, Abdulraheem, Murungi,
Obimbo, Aremu, Osano, Cheruiyot,
Ilomuanya, Mwangi and Kigondu. This is
an open-access article distributed under
the terms of the Creative Commons
Attribution License (CC BY). The use,
distribution or reproduction in other
forums is permitted, provided the original
author(s) and the copyright owner(s) are
credited and that the original publication
in this journal is cited, in accordance with
accepted academic practice. No use,
distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Pharmacology 01 frontiersin.org
intravaginal exposure for 10 days revealed absent-to-mild cervicovaginal changes.
Chemical fingerprinting putatively annotated flavonoid-, tannin-, and phenolicrelated features, including catechin, quercetin derivatives, rutin, corilagin, and
kaempferol glycosides, as prominent features of KBLM.
Conclusion: Our findings have demonstrated the sperm disruption activity of the
methanolic fraction of F. virosa root bark. The observed disruption of multiple
sperm functions, observed efficacy in a rabbit model and absent-to-mild shortterm local tissue changes support additional preclinical investigations of the extract
geared towards further functional characterization, extended safety testing,
standardization, and potential formulation of an intravaginal contraceptive. |
en_US |